SHANNON SPRENKLE: Open Payments
NPI 1013384072 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 14 payments from 3 companies in 2025. Trend: 2023 $371 · 2024 $830 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $262 |
| Verona Pharma, Inc. | 2 | $149 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
Products named: NUCALA, Ohtuvayre, TEZSPIRE, FASENRA.
Industry payments across MD — which companies pay providers there.
